+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Oropharyngeal Candidiasis - Global Strategic Business Report - Product Thumbnail Image

Oropharyngeal Candidiasis - Global Strategic Business Report

  • Report
  • September 2025
  • 462 Pages
  • Global
From
Gout Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Gout Disease Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 473 Pages
  • Global
From
Axial Spondyloarthritis (AXSPA) - Global Strategic Business Report - Product Thumbnail Image

Axial Spondyloarthritis (AXSPA) - Global Strategic Business Report

  • Report
  • September 2025
  • 182 Pages
  • Global
From
Spinal Pumps - Global Strategic Business Report - Product Thumbnail Image

Spinal Pumps - Global Strategic Business Report

  • Report
  • September 2025
  • 366 Pages
  • Global
From
Testosterone Booster Supplements - Global Strategic Business Report - Product Thumbnail Image

Testosterone Booster Supplements - Global Strategic Business Report

  • Report
  • September 2025
  • 373 Pages
  • Global
From
Trachoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Trachoma Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 285 Pages
  • Global
From
From
Uropathy Treatment - Global Strategic Business Report - Product Thumbnail Image

Uropathy Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 271 Pages
  • Global
From
From
Postpartum Depression Drugs - Global Strategic Business Report - Product Thumbnail Image

Postpartum Depression Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 479 Pages
  • Global
From
Edema Clinical Trials - Global Strategic Business Report - Product Thumbnail Image

Edema Clinical Trials - Global Strategic Business Report

  • Report
  • September 2025
  • 461 Pages
  • Global
From
Dyspepsia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dyspepsia Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 566 Pages
  • Global
From
Pediatric Diabetes Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pediatric Diabetes Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 464 Pages
  • Global
From
Respiratory Disease Vaccines - Global Strategic Business Report - Product Thumbnail Image

Respiratory Disease Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 475 Pages
  • Global
From
Urokinase - Global Strategic Business Report - Product Thumbnail Image

Urokinase - Global Strategic Business Report

  • Report
  • September 2025
  • 279 Pages
  • Global
From
Ursodeoxycholic Acid - Global Strategic Business Report - Product Thumbnail Image

Ursodeoxycholic Acid - Global Strategic Business Report

  • Report
  • September 2025
  • 468 Pages
  • Global
From
Dry Eye Treatment Devices - Global Strategic Business Report - Product Thumbnail Image

Dry Eye Treatment Devices - Global Strategic Business Report

  • Report
  • September 2025
  • 281 Pages
  • Global
From
Hyperhidrosis Treatment - Global Strategic Business Report - Product Thumbnail Image

Hyperhidrosis Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 480 Pages
  • Global
From
Artemisinic Acid - Global Strategic Business Report - Product Thumbnail Image

Artemisinic Acid - Global Strategic Business Report

  • Report
  • September 2025
  • 170 Pages
  • Global
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more